Major Pharmaceutical Company Signs Long-Term Lease at LINK Geneva
A leading pharmaceutical company has signed a long-term lease for 2,100 sqm at LINK Geneva, citing ESG reporting capabilities as a key decision factor.
LINK Geneva announces the signing of a major pharmaceutical tenant for 2,100 sqm of premium office space. ## Decision Factors The tenant, a mid-sized pharmaceutical company with 180 Geneva-based employees, selected LINK primarily for its ESG reporting capabilities and verified energy performance data. "We needed a building that could support our CSRD reporting requirements with verifiable data," explained the tenant's real estate director. "LINK's 250+ sub-meters and years of actual consumption data gave us the confidence to commit." ## Fit-Out Timeline The fit-out is scheduled to complete in Q4 2024, with LINK's in-house project team coordinating the build-out. For leasing inquiries, contact: leasing@link-geneva.ch
Media Inquiries
For more information, interviews, or media assets, please contact our communications team.